# Filing Detail

Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-19-010251
Filing Date
2019-05-16
Accepted
2019-05-16 16:36:43
Documents
13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM S-3 | dffn20190514_s3.htm | S-3 | 393548
2 | EXHIBIT 4.1 | ex_145198.htm | EX-4.1 | 1529
3 | EXHIBIT 4.3 | ex_144952.htm | EX-4.3 | 319030
4 | EXHIBIT 5.1 | ex_144951.htm | EX-5.1 | 30085
5 | EXHIBIT 23.1 | ex_145199.htm | EX-23.1 | 4004
6 |  | a1.jpg | GRAPHIC | 10029
7 |  | a2.jpg | GRAPHIC | 12367
8 |  | dffn20190514_s3img003.gif | GRAPHIC | 40946
9 |  | dffn20190514_s3img004.gif | GRAPHIC | 41077
10 |  | ex01.jpg | GRAPHIC | 219727
11 |  | ex02.jpg | GRAPHIC | 179657
12 |  | logox.jpg | GRAPHIC | 13617
13 |  | s3img002.jpg | GRAPHIC | 43900
| Complete submission text file | 0001437749-19-010251.txt |  | 1512677

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231541 | Film No.: 19832812
SIC: 2834 Pharmaceutical Preparations